NL-OMON22101已完成不适用
A pharmacokinetic study of docetaxel and prednisone in men with metastatic castration-resistant or hormone-sensitive orostate cancer.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 18
研究概览
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Histologicallly or cytologically confirmed adenocarcinoma of the prostate without neuro-endocrine differentitation or small cell features.
- •2. Continued androgen deprivation therapy either by gonadotropin releasing hormone (GnRH) analogues or orchiedectomy
排除标准
- •1. Impossibility or unwillingness to take oral drugs
- •2. Serious concurrent illness or medical unstable condition requiring treatment
研究者
相似试验
已完成
不适用
A pharmacokinetic study of Docetaxel and Prednisone in men with metastatic castration-resistant or hormone-sensitive prostate cancer.10038597metastatic prostate cancerNL-OMON42925Erasmus MC, Universitair Medisch Centrum Rotterdam18
进行中（未招募）
1 期
A study to determine the influence of prednisone on the bioavailability and metabolisation of docetaxel.Metastatic prostate cancerEUCTR2016-001269-10-NLErasmus MC Cancer Institute18
进行中（未招募）
1 期
A phase I/II study of docetaxel plus prednisolone plus diethylstilbestrol plus aspirin in androgen-independent prostate cancerHormone refractory prostate cancerEUCTR2005-002027-13-GBRoyal Marsden NHS FOundation Trust37
进行中（未招募）
不适用
A Phase 1b/2 Study of Docetaxel and Prednisone, with or without ISIS 183750 (an eIF4E Inhibitor), inPatients with Castrate-Resistant Prostate Cancer - N/AEUCTR2010-022239-12-HUIsis Pharmaceuticals, Inc.112
招募中
不适用
Pharmacokinetic analysis of docetaxel and dexamethasone in combination with aprepitant in Japanese patients with solid tumors.cancerJPRN-UMIN000007629Saitama Medical University, International Medical Center30